The Role of Skin Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity

被引：0
|
作者：
Cohen, Philip R. [1 ,2 ]
机构：
[1] Univ Calif Sacramento, Davis Med Ctr, Dept Dermatol, Sacramento, CA 95819 USA
[2] Touro Univ Calif, Coll Osteopath Med, Vallejo, CA USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 10期
关键词：
D O I：
10.6004/jnccn.2022.7062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Sophia Bylsma
    Karen Yun
    Sandip Patel
    Michael J Dennis
    Current Treatment Options in Oncology, 2022, 23 : 1153 - 1168
  • [22] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Bylsma, Sophia
    Yun, Karen
    Patel, Sandip
    Dennis, Michael J.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) : 1153 - 1168
  • [23] At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity
    Young, Arabella
    Bluestone, Jeffrey A.
    CANCER DISCOVERY, 2021, 11 (03) : 537 - 539
  • [24] Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
    Fernando Bessone
    Einar Stefan Bjornsson
    World Journal of Hepatology, 2022, 14 (07) : 1269 - 1276
  • [25] Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
    Bessone, Fernando
    Bjornsson, Einar Stefan
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (07) : 1269 - 1276
  • [26] Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series
    Harvey, Catriona
    Nahar, Kazi J.
    Mckeown, Janet
    Lo, Serigne N.
    Farag, Sheima
    Yousaf, Nadia
    Young, Kate
    Tas, Liselotte
    Meerveld-Eggink, Aafke
    Blank, Christian
    Thomas, Austin
    Mcquade, Jennifer
    Schilling, Bastian
    Johnson, Douglas B.
    Huertas, Roberto Martin
    Arance, Ana
    Lee, Joanna
    Zimmer, Lisa
    Long, Georgina, V
    Carlino, Matteo S.
    Wang, Yinghong
    Menzies, Alexander Maxwell
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [27] The usefulness of liver biopsy in immune checkpoint inhibitor-induced liver injury diagnosis and management
    Komuta, M.
    Izai, R.
    Ogasawara, S.
    Sawada, M.
    Yumita, S.
    Nakagawa, M.
    Kojima, R.
    Koroki, K.
    Kanzaki, H.
    Inoue, M.
    Nakamura, M.
    Kanogawa, N.
    Kondo, T.
    Nakamoto, S.
    Kato, N.
    VIRCHOWS ARCHIV, 2024, 485 : S69 - S69
  • [28] LIVER BIOPSY IS OF LIMITED UTILITY IN THE DIAGNOSIS AND MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR HEPATITIS IN CANCER PATIENTS
    Li, Michael
    Sack, Jordan
    Wong, Danny
    Grover, Shilpa
    Zucker, Stephen D.
    GASTROENTEROLOGY, 2021, 160 (06) : S769 - S769
  • [29] Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
    Vasbinder, Alexi
    Ismail, Anis
    Salem, Joe-Elie
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (09) : 959 - 967
  • [30] Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
    Alexi Vasbinder
    Anis Ismail
    Joe-Elie Salem
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 959 - 967
12345